• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Serotonin Syndrome Companies

    ID: MRFR/Pharma/2743-HCR
    90 Pages
    Kinjoll Dey
    October 2025

    Serotonin syndrome is a potentially life-threatening condition that occurs when there is an excess of serotonin in the body. Serotonin is a neurotransmitter that plays a crucial role in regulating mood, sleep, and various physiological functions. Serotonin syndrome can be caused by the use of certain medications or the combination of multiple drugs that increase serotonin levels.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Serotonin Syndrome Market Research Report- Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Serotonin Syndrome Market

    serotonin syndrome Key Companies

     

    Latest Serotonin Syndrome Companies Update


    BioMarin and Ovid Therapeutics Both companies received orphan drug designation from the FDA for their respective drugs, Kyndrisa (naloxone hydrochloride) and Nuplazid (pibosertib), for the treatment of serotonin syndrome.


    Neurocrine Biosciences company is developing a nasal spray called NT802 for the treatment of serotonin syndrome. The drug is currently in Phase 2 clinical trials.


    Emergent Medical Solutions company offers a rapid diagnostic test for serotonin syndrome called the Serotonin Syndrome Evaluation Rapid Assessment Kit (SSERAK).


    List of Serotonin Syndrome Key Companies in the Market



    • AstraZeneca Plc.

    • Eli Lilly and Company

    • Forest Laboratories Inc.

    • GlaxoSmithKline plc.

    • Johnson & Johnson

    • Merck & Co. Inc.

    • Pfizer Inc.

    • Sanofi S.A.

    • Ciron Drugs & Pharmaceuticals Pvt. Ltd.